Guy Neev is CEO of Check-Cap, an Israeli-based medical diagnostics startup that is poised to transform colorectal screening.
Colon cancer is the third most common cancer to be diagnosed in the U.S., excluding skin cancer and the American Cancer Society projects nearly 94,000 cases of colon cancer in 2015 alone. Higher rates of colorectal screening can help to prevent deaths related to this prevalent disease and yet the process that patients are required to undergo the screening is onerous.
People need to be on clear liquid diet for a few days and take medication to cleanse the bowel that leads to diarrhea-like outcomes. Check-Cap aims to eliminate all that. The company is developing a small capsule that can be ingested and which images the colon as the person goes about his or her daily routine. Patients consume a small amount of contrast with their meals to help the capsule do the imaging. Once excreted out, the data recorded can be analyzed by a physician.
The very low dose X-ray radar device can take 2-D and 3-D images of the colon. The product is being tested to obtain CE Mark this year.
[image courtesy of executive search firm KFA Search]